Nanoparticles, Plastics, and Nanoplastics for Improved Health
Designing safer, smarter nanoparticles for health
Learn More
Research Project
88 •
Challenge
Nanoparticles are now entering clinical trials, but researchers quickly realise that a one-sizefits-all solution simply doesn ' t work. Small adjustments, like changing the therapeutic drug they carry, can transform a once-efficient delivery system into a toxic hazard with serious side effects. By understanding these critical links, this team can develop better, customised nanoparticles that are safer and more effective.
Solution
This research examines the creation and study of nanosized formulations made from polymers, as well as their interactions with the biological environment. It uses precise synthesis techniques and advanced analytical tools to characterise these materials.
By understanding the physicochemical properties of these nanoparticles, their activity and fate within a biological system
can be determined. With this understanding, nanoparticles can be redesigned to suit specific applications and maximise their effectiveness.
Target customers / end-users
• industry and clinicians to reate improved formulations
• food, cosmetics and agriculture sectors
• government.
Progress
• > AU $ 10m in research grant support
• almost 500 publications( 30,000 citations), 10 patents and 80 + keynote lectures citations
• collaborated with industry on various plastic and nanoparticles projects.
Basic research
TRL 4
Multidisciplinary team
Research Project
Nanoparticles hold the remarkable potential to revolutionise drug delivery, especially in critical areas such as cancer treatment and vaccination. However, realising this potential depends on a deep understanding of their true nature. The unique properties of nanoparticles determine whether they will deliver life-saving benefits or pose risks.